JP2024538128A5 - - Google Patents
Info
- Publication number
- JP2024538128A5 JP2024538128A5 JP2024522501A JP2024522501A JP2024538128A5 JP 2024538128 A5 JP2024538128 A5 JP 2024538128A5 JP 2024522501 A JP2024522501 A JP 2024522501A JP 2024522501 A JP2024522501 A JP 2024522501A JP 2024538128 A5 JP2024538128 A5 JP 2024538128A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroalkyl
- cancer
- optionally substituted
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256057P | 2021-10-15 | 2021-10-15 | |
| US63/256,057 | 2021-10-15 | ||
| US202263390438P | 2022-07-19 | 2022-07-19 | |
| US63/390,438 | 2022-07-19 | ||
| PCT/US2022/046761 WO2023064586A1 (en) | 2021-10-15 | 2022-10-14 | Novel modulators of ehmt1 and ehmt2 and therapeutic use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538128A JP2024538128A (ja) | 2024-10-18 |
| JP2024538128A5 true JP2024538128A5 (https=) | 2025-10-21 |
Family
ID=84357982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522501A Pending JP2024538128A (ja) | 2021-10-15 | 2022-10-14 | Ｅｈｍｔ１及びｅｈｍｔ２の新規調節因子及びその治療用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240368139A1 (https=) |
| EP (1) | EP4416143A1 (https=) |
| JP (1) | JP2024538128A (https=) |
| KR (1) | KR20240148310A (https=) |
| AU (1) | AU2022366869A1 (https=) |
| CA (1) | CA3234693A1 (https=) |
| IL (1) | IL311999A (https=) |
| MX (1) | MX2024004416A (https=) |
| WO (1) | WO2023064586A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116602242B (zh) * | 2023-05-08 | 2024-01-23 | 中国水产科学研究院珠江水产研究所 | 一种提高反季鱼苗成活率的方法 |
| WO2025155882A1 (en) * | 2024-01-19 | 2025-07-24 | Icahn School Of Medicine At Mount Sinai | G9a/glp degradation / disruption compounds and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| PL3442947T3 (pl) * | 2016-04-15 | 2023-10-02 | Epizyme, Inc. | Związki arylowe lub heteroarylowe podstawione aminą jako inhibitory ehmt1 i ehmt2 |
| US20200039998A1 (en) * | 2016-12-19 | 2020-02-06 | Epizyme, Inc. | Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof |
| US20200113901A1 (en) * | 2017-03-31 | 2020-04-16 | Epizyme, Inc. | Methods of using ehmt2 inhibitors |
| CN110621316B (zh) * | 2017-04-21 | 2024-01-26 | Epizyme股份有限公司 | 用ehmt2抑制剂进行的组合疗法 |
| JP2021500326A (ja) * | 2017-10-18 | 2021-01-07 | エピザイム，インコーポレイティド | 血液障害の予防又は処置にｅｈｍｔ２阻害剤を使用する方法 |
| AU2018353139A1 (en) * | 2017-10-18 | 2020-06-04 | Epizyme, Inc. | Methods of using EHMT2 inhibitors in immunotherapies |
-
2022
- 2022-10-14 JP JP2024522501A patent/JP2024538128A/ja active Pending
- 2022-10-14 KR KR1020247016027A patent/KR20240148310A/ko active Pending
- 2022-10-14 MX MX2024004416A patent/MX2024004416A/es unknown
- 2022-10-14 US US18/701,092 patent/US20240368139A1/en active Pending
- 2022-10-14 AU AU2022366869A patent/AU2022366869A1/en active Pending
- 2022-10-14 IL IL311999A patent/IL311999A/en unknown
- 2022-10-14 CA CA3234693A patent/CA3234693A1/en active Pending
- 2022-10-14 WO PCT/US2022/046761 patent/WO2023064586A1/en not_active Ceased
- 2022-10-14 EP EP22802794.2A patent/EP4416143A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024538128A5 (https=) | ||
| JP2025160318A5 (https=) | ||
| TWI798446B (zh) | 作為核轉運調節劑之化合物及其用途 | |
| JP2020503363A5 (https=) | ||
| HRP20160625T1 (hr) | Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka | |
| JP2022515198A5 (https=) | ||
| CN111247152B (zh) | 作为激酶抑制剂的环状亚氨基嘧啶衍生物 | |
| JP2020527173A5 (https=) | ||
| RU2018102365A (ru) | Новые гидроксисложноэфирные производные, способ их получения и фармацевтические композиции, содержащие их | |
| RU2016102036A (ru) | Производное хинолина | |
| JP2023533203A5 (https=) | ||
| IL274504B2 (en) | Acss2 inhibitors and methods of use thereof | |
| JP2014513704A5 (https=) | ||
| JP2018511628A5 (https=) | ||
| RU2016130986A (ru) | Ингибитор киназы и его применение | |
| JP2007511504A5 (https=) | ||
| CA3035860A1 (en) | Pyridine compound | |
| JP2021514395A5 (https=) | ||
| JP2020063289A5 (https=) | ||
| CA2991360A1 (en) | 2-aryl- and 2-arylalkyl-benzimidazoles as midh1 inhibitors | |
| JP2023534528A5 (https=) | ||
| JP2023531970A5 (https=) | ||
| JP2009504771A5 (https=) | ||
| JP2017534569A (ja) | ＰＩ３Ｋ、ｍＴＯＲ阻害薬としての縮合キノリン化合物 | |
| JP2024543207A5 (https=) |